As the Centers for Medicare & Medicaid Services (CMS) cuts fee-for-service Medicare rates and Medicare Advantage (MA) penetration continues, top-tier home health companies are looking for top-tier payers to work with. Enhabit Inc. (NYSE: EHAB) considers itself a top-tier provider – regularly pointing toward its 30-day hospitalization rate, which was 20.5% below the national average […]
Category: Medicare Advantage
The value-based and home-based care enablement platform CareCentrix is in an interesting position. Not only is it in between home health providers and Medicare Advantage (MA) plans, but it’s also now owned by Walgreens Boots Alliance (Nasdaq: WBA) – one of the retailers diving head first into home-based health care services. In a recent conversation […]
Home health providers want better rates and arrangements from Medicare Advantage (MA) plans. The plans, on the other hand, sometimes still can’t figure out what they want from providers. Some of the largest home health companies have begun to make headway with MA plans. “I think the payers are recognizing that this is not a […]
Medicare Advantage (MA) – the offshoot of traditional Medicare that’s administered by private insurance companies – has recently caught a lot of flak. As it pertains to home health care specifically, MA plans have been criticized for their cumbersome prior authorization requirements and provider reimbursement rates that are typically far below fee-for-service Medicare. What’s more, […]
A new study of Medicare Advantage (MA) beneficiaries found that in-home companion care reduced care costs by close to 10%. The study – conducted by a national actuarial firm and commissioned by the companion care company Papa – also found that in-home companion care boosted home health utilization among MA members, while reducing more costly […]
If there were ever a time for Medicare Advantage-related troubles to cool off in the home health care space, now would be it. And, heading into the summer, some of the largest home health providers in the country are scoring demonstrable wins that could lead to future success. Virtually no one has the MA game […]
Humana Inc. (NYSE: HUM) announced Monday that Jim Rechtin would be succeeding Bruce Broussard in the CEO role on July 1. On Tuesday, Broussard explained why. Ultimately, the CEO succession plan had been in place at Humana for a while. Broussard has served in the CEO chair since 2013, and Rechtin was named his successor […]
Jim Rechtin, who was named Bruce Broussard’s successor at Humana Inc. (NYSE: HUM) in October of last year, will officially take over on July 1, the company announced Monday. Rechtin joined Humana as president and COO in January, and will also join the board of directors on July 1 when he transitions to CEO. “I […]
At a time when many home care providers are shutting the door on Medicare Advantage (MA), Avid Health at Home has managed to go the other way. Avid Health at Home is a home care platform backed by Havencrest Capital. The company believes that demonstrating its value through data could be what puts it in […]
Both home health care and Medicare Advantage (MA) are currently in rough rate environments. But Humana Inc. (NYSE: HUM) leaders believe in the company’s ability to continue growing MA membership with solid margins, partly by leaning into CenterWell Home Health and its other provider assets. Earlier this month, the Centers for Medicare & Medicaid Services […]